ARDMORE, OK-- Statistics show people with diabetes have a 65% greater risk of developing Alzheimer's. Now, the same insulin used for diabetics could be used to help treat Alzheimer's patients. Amanda Brown has more on what this study could mean for people in our area
A recent pilot study in the Journal Archives of Neurology has suggested that inhaling insulin could play a part in helping individuals improve memory and even reverse symptoms of memory loss. Pharmacist Rebecca Reed said the research is still underway, but if the insulin does prove to work, it would be great news to Oklahoma because of the large community of diabetics. She said that a lot of diabetics do not know they are at great risk to the Alzheimer's disease and that it is just one of the possible complications that diabetes can bring.
"If you don't take care of yourself then your going to have more problems and complications and this is just one of the complications," she said.
Ann O'Conner was diagnosed with type two diabetes two years ago and said she is well aware of the complications it could produce. The recent study is good news to O'Conner, she said diabetes runs her family and her current roommate suffers from dementia.
"I see her just going downhill everyday you know and its heartbreaking," she said.
O'Connor said she is at ease knowing there is research being done to tackle memory loss, because if she is diagnosed with Alzheimer's, at least there's a chance they have found something that would help.
Study found more germs and a wider variety of bacterial types in houses with dogs
But it's unclear what the finding might mean for patients
Hopelessness, disability may play a role in feelings of despair, study finds
But questions remain about widespread screening
Patients thought to have lung condition were re-evaluated in small study
NEW YORK (AP) — The nation's record-low teen birth rate stems from robust declines in nearly every state, but most dramatically in several Mountain States and among Hispanics, according to a new government report.
WARSAW, Poland (AP) — A 33-year-old Polish man received a face transplant just three weeks after being disfigured in a workplace accident, in what his doctors said Wednesday is the fastest time frame to date for such an operation. It was Poland's first face transplant.
By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success could come by taming the superbug MRSA, a drug-resistant bacterium that she has seen ravage a healthy man up close and personally. Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than $20 billion a year to treat. ...